V. Saravanan

ORCID: 0000-0001-5770-2845
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • X-ray Diffraction in Crystallography
  • Crystallization and Solubility Studies
  • Rheumatoid Arthritis Research and Therapies
  • Salivary Gland Disorders and Functions
  • Sulfur-Based Synthesis Techniques
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Systemic Sclerosis and Related Diseases
  • Systemic Lupus Erythematosus Research
  • Sarcoidosis and Beryllium Toxicity Research
  • Plant Virus Research Studies
  • Organoselenium and organotellurium chemistry
  • Lymphoma Diagnosis and Treatment
  • Synthesis and Catalytic Reactions
  • Vasculitis and related conditions
  • Growth Hormone and Insulin-like Growth Factors
  • Synthesis and biological activity
  • Catalytic C–H Functionalization Methods
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Transgenic Plants and Applications
  • Connective tissue disorders research
  • Bacteriophages and microbial interactions
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Advanced Synthetic Organic Chemistry
  • Viral Infectious Diseases and Gene Expression in Insects
  • Chemical Synthesis and Analysis

Queen Elizabeth Hospital
2014-2024

Saveetha University
2023

Versus Arthritis
2023

University of Manchester
2023

Manchester Academic Health Science Centre
2023

Gateshead Health NHS Foundation Trust
2009-2022

Jubilant Life Sciences (India)
2016-2021

University of Madras
2013-2015

Newcastle University
2014

Jain University
2014

BackgroundImmunosuppressive treatments inhibit vaccine-induced immunity against SARS-CoV-2. We evaluated whether a 2-week interruption of methotrexate treatment immediately after the COVID-19 vaccine booster improved antibody responses S1 receptor-binding domain (S1-RBD) SARS-CoV-2 spike protein compared with uninterrupted in patients immune-mediated inflammatory diseases.MethodsWe did an open-label, prospective, two-arm, parallel-group, multicentre, randomised, controlled, superiority trial...

10.1016/s2213-2600(22)00186-2 article EN cc-by The Lancet Respiratory Medicine 2022-06-27

Background Fatigue is a debilitating condition with significant impact on patients' quality of life. frequently reported by patients suffering from primary Sjögren's Syndrome (pSS), chronic autoimmune characterised dryness the eyes and mouth. However, although fatigue common in pSS, it does not manifest all sufferers, providing an excellent model which to explore potential underpinning biological mechanisms. Methods Whole blood samples 133 fully-phenotyped pSS stratified for presence...

10.1371/journal.pone.0143970 article EN cc-by PLoS ONE 2015-12-22
Jessica Tarn Nadia Howard-Tripp Dennis Lendrem Xavier Mariette Alain Saraux and 95 more Valérie Devauchelle‐Pensec Raphaèle Séror Andrew Skelton Katherine James Peter McMeekin Shereen Al-Ali Katie L. Hackett Clare Lendrem Ben Hargreaves John Casement Sheryl Mitchell Simon J Bowman Elizabeth Price Colin Pease Paul Emery Peter Lanyon John Hunter Monica Gupta Stefano Bombardieri Nurhan Sutcliffe Costantino Pitzalis John McLaren Annie Cooper Marian Regan Ian Giles David Isenberg V. Saravanan David Coady Bhaskar Dasgupta Neil McHugh Steven Young‐Min Robert J. Moots Nagui Gendi Mohammed Akil Bridget Griffiths Svein Joar Auglænd Johnsen Katrine Brække Norheim Roald Omdal Deborah Stocken Colin Everett Catherine Fernandez John D. Isaacs Jacques‐Eric Gottenberg Wan‐Fai Ng Valérie Devauchelle‐Pensec Philippe Dieudé Jean Jacques Dubost Anne-Laure Fauchais Vincent Goëb É. Hachulla C. Larroche Véronique Le Guern Jacques Morel Aleth Perdriger Xavier Puéchal S. Rist Damien Sen Jean Sibilia Olivier Vittecoq Joëlle Bénessiano Sarah Tubiana Karine Inamo Stanie Gaëte Djilali Batouche Domitille Molinari Mickael Randrianandrasana Isabelle Pane Adeline Abbé Gabriel Baron Philippe Ravaud Jacques-Eric Gottenberg Philippe Ravaud Xavier Puéchal Véronique Le Guern Jean Sibilia C. Larroche Alain Saraux Valérie Devauchelle-Pensec Jacques Morel Gilles Hayem P.Y. Hatron Aleth Perdriger Damien Sene Charles Zarnitsky Djilali Batouche Valérie Furlan Joëlle Bénessiano Élodie Perrodeau Raphaèle Séror Xavier Mariette Samuel M. Brown N. Navarro Saaeha Rauz Paul Emery Sue Pavitt

Heterogeneity is a major obstacle to developing effective treatments for patients with primary Sjögren's syndrome. We aimed develop robust method stratification, exploiting heterogeneity in patient-reported symptoms, and relate these differences pathobiology therapeutic response.

10.1016/s2665-9913(19)30042-6 article EN cc-by The Lancet Rheumatology 2019-09-25

EuroQoL-5 dimension (EQ-5D) is a standardised preference-based tool for measurement of health-related quality life and EQ-5D utility values can be converted to quality-adjusted years (QALYs) aid cost-utility analysis. This study aimed evaluate the 639 patients with primary Sjögren's syndrome (PSS) in UK.Prospective data collected using pro forma were compared UK normative data. Relationships between clinical laboratory features PSS explored.The proportion reporting any problem mobility,...

10.1136/annrheumdis-2012-202863 article EN Annals of the Rheumatic Diseases 2013-06-12

Objectives This article reports relationships between serum cytokine levels and patient-reported of fatigue, in the chronic immunological condition primary Sjögren's syndrome (pSS). Methods Blood 24 cytokines were measured 159 patients with pSS from United Kingdom Primary Syndrome Registry 28 healthy non-fatigued controls. Differences cases controls evaluated using Wilcoxon test. Patient-reported scores for fatigue evaluated, classified according to severity compared analysis variance....

10.1136/rmdopen-2016-000282 article EN cc-by RMD Open 2016-07-01

Fibromyalgia and joint hypermobility are common coexisting conditions among younger females that often accompanied with additional features of autonomic dysfunction. Mental health is frequently impacted these an association neurodivergence has been recently established. Neurodivergence also prevalent close relatives. Reasons for this poorly understood, although genetics, adverse early life experiences autoimmunity all contribute. Pharmacological responses may differ in neurodivergence, while...

10.17925/rmd.2022.1.1.3 article EN cc-by-nc touchREVIEWS in RMD 2022-01-01

<h3>Introduction</h3> Immunisation against pneumococcus has been shown to reduce pneumonia in rheumatoid arthritis (RA). There is concern that methotrexate may its efficacy. are very few objective data on the effect of efficacy pneumococcal vaccination with pneumovax, and no evidence whether revaccination necessary RA patients methotrexate. <h3>Methods</h3> The authors collected information from 180 relating their status assayed antibody levels. Data pulmonary infection were retrieved same...

10.1136/ard.2010.144451 article EN Annals of the Rheumatic Diseases 2011-04-22

To determine the prevalence of autonomic dysfunction (dysautonomia) among patients with primary Sjögren's syndrome (PSS) and relationships between dysautonomia other clinical features PSS.Multicentre, prospective, cross-sectional study a UK cohort 317 clinically well-characterised PSS. Symptoms were assessed using validated instrument, Composite Autonomic Symptom Scale (COMPASS). The data compared an age- sex-matched community controls. symptoms various PSS analysed regression...

10.1136/annrheumdis-2011-201009 article EN cc-by-nc Annals of the Rheumatic Diseases 2012-05-05

In order to develop interventions optimize MTX use for the treatment of RA we evaluated rate of, reasons and predictors non-adherence during first 6 months therapy.The Rheumatoid Arthritis Medication Study (RAMS) is a prospective multicentre cohort study incident users in UK. Prior commencement demographic, clinical psychological data were collected. A weekly patient-completed diary recorded dose, possible side effects adherence over 26 weeks. The number non-adherent weeks was calculated....

10.1093/rheumatology/kez274 article EN cc-by-nc Lara D. Veeken 2019-06-12

Abstract Objectives To estimate prevalence rates and identify baseline predictors of adverse events (AEs) over the first year treatment in patients with RA starting MTX. Methods Data came from UK Rheumatoid Arthritis Medication Study (RAMS), a prospective cohort This analysis included aged ≥18 years physician diagnosed symptom duration ≤2 years, who were commencing MTX for time. AEs recorded by interviewing at 6- 12-month follow-up visits. The period are reported 0–6 months, 6–12 months 0–12...

10.1093/rheumatology/keab917 article EN cc-by-nc Lara D. Veeken 2022-01-24

ABSTRACT Introduction Anaemia is common in rheumatoid arthritis (RA). Clinicians may focus on rheumatological issues and assume anaemia of chronic disease (ACD). This study challenged this assumption investigated the causes a large cohort RA patients to assess its implications. Methods The hospital where was conducted monitors regular full blood count erythrocyte sedimentation rate (ESR) monthly all modifying drugs efficacy safety. A computerised system identifies records abnormal results....

10.1136/pgmj.2011.117507 article EN Postgraduate Medical Journal 2011-06-09

BackgroundMethotrexate is the first-line treatment for immune-mediated inflammatory diseases and reduces vaccine-induced immunity. We evaluated if a 2-week interruption of methotrexate immediately after COVID-19 booster vaccination improved antibody response against S1 receptor binding domain (S1-RBD) SARS-CoV-2 spike protein live neutralisation compared with uninterrupted in patients diseases.MethodWe did multicentre, open-label, parallel-group, randomised, superiority trial secondary-care...

10.1016/s2665-9913(23)00298-9 article EN cc-by The Lancet Rheumatology 2023-12-12

To develop a novel method for capturing the discrepancy between objective tests and subjective dryness symptoms (a sensitivity scale) to explore predictors of sensitivity.Archive data from UK Primary Sjögren's Syndrome Registry (n = 688) were used. Patients classified on scale -5 (stoical) +5 (sensitive) depending degree their classes. Sensitivity scores correlated with demographic variables, disease-related factors, pain, fatigue, anxiety, depression.Patients average relatively stoical both...

10.1002/acr.23165 article EN cc-by Arthritis Care & Research 2016-12-19

Abstract Objective GCA is the commonest primary systemic vasculitis in adults, with significant health economic costs and societal burden. There wide variation access to secondary care services, 34% of hospitals England not having any formal clinical pathway. Quality standards provide levers for change improve services. Methods The multidisciplinary steering committee were asked anonymously put forward up five aspects service essential best practice. Responses qualitatively analysed identify...

10.1093/rheumatology/kead025 article EN Lara D. Veeken 2023-01-24

The aim of the study was to evaluate levels physical activity in individuals with primary Sjögren's syndrome (PSS) and its relationship clinical features PSS. To this cross-sectional study, self-reported from 273 PSS patients were measured using International Physical Activity Questionnaire-short form (IPAQ-SF) compared healthy controls matched for age, sex body mass index. Fatigue other aspects including disease status, dryness, daytime sleepiness, dysautonomia, anxiety depression assessed...

10.1007/s00296-016-3637-6 article EN cc-by Rheumatology International 2016-12-24
Coming Soon ...